Journal Mobile Options
Table of Contents
Vol. 55, No. 4, 2009
Issue release date: December 2009
Ann Nutr Metab 2009;55:351–357
(DOI:10.1159/000252351)

Relation between Body Fat and Liver Fat Accumulation and Cytokine Pattern in Non-Alcoholic Patients with Chronic HCV Infection

González-Reimers E. · Castellano-Higuera A. · Alemán-Valls R. · Alvarez-Argüelles H. · de la Vega-Prieto M.J. · Abreu-González P. · López-Prieto J. · Santolaria-Fernández F. · Valladares-Parrilla F.
Servicios deaMedicina Interna, bAnatomía Patológica, cLaboratorio, Hospital Universitario de Canarias, dDepartamento de Fisiología, Facultad de Medicina, Universidad de La Laguna, La Laguna, Spain

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Liver steatosis in chronic hepatitis C virus (HCV) infection is multifactorial. Therefore, there is not necessarily a relation between obesity and liver fat.On the other hand, body fat secretes cytokines, and cytokines and oxidative damage play important roles on progression of liver disease. Methods: We analyzed the relationships between liver fat (assessed by histomorphometry) and trunk and subcutaneous fat (waist perimeter, triceps skinfold, BMI); the relationships between liver and body fat and cytokines (IL-6, TNF-α, IL-8, IFN-γ, IL-4), adipokines (adiponectin and TIMP-1), and serum malondiladehyde and antioxidants (glutathione peroxidase and superoxide dismutase (SOD) activities); and the relationships of these data with histological changes in 40 HCV-infected non-alcoholic patients. Results: Significant correlations were found between liver fat and waist perimeter and BMI, and between serum TIMP-1 and liver fat. Serum TIMP-1 was significantly related to body fat stores; serum IL-6 and IFN-γ were related to histological inflammation. Patients with waist perimeter >102 cm (men) or 88 cm (women) showed increased liver fat. In 38.8% of non-obese patients, liver fat accumulation was intense. Conclusions: There is a relationship between visceral fat, serum TIMP-1 and liver steatosis. However, at least in some patients, factors different from mere adiposity play a role in liver steatosis.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Knodell KG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431–435.
  2. Bedossa P, Bioulac-Sage P, Callard P, Chevallier M, Degott C, Deugnier C and the French Metavir cooperative Study Group: Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15–20.
  3. Negro F: Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J Gastroenterol 2006;12:6756–6765.
  4. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Scaff Z, Chapman MJ, Miyamura T, Bréchot C: Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 1997;94:1200–1205.
  5. Björnsson E, Angulo P: Hepatitis C and steatosis. Arch Med Res 2007;38:621–627.
  6. Diehl AM: Obesity and alcoholic liver disease. Alcohol 2004;34:81–87.
  7. Lieber CS: Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9–19.
  8. El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460–468.
  9. Sutinen J, Korsheninnikova E, Funahashi T, Matzusawa Y, Nyman T, Yki-Järvinen H: Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. J Clin Endocrinol Metab 2003;88:1907–1910.
  10. Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ: Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 2008;47:2127–2133.
  11. McClain CJ, Mokshagundam SPL, Barve SS, Song Z, Hill DB, Chen T, Deaciuc I: Mechanisms of non-alcoholic steatohepatitis. Alcohol 2004;34:67–79.
  12. Xu A, Wang Y, Keshaw H, Xu LY, Lam KSL, Cooper GJS: The fat-derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver diseases in mice. J Clin Invest 2003;112:91–100.
  13. Sorensen IV, Fenger C, Winther H, Foged NT, Lademan U, Brünner N, Usher PA: Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in Formalin-fixed, Paraffin-embedded tissue. J Histochem Cytochem 2006;54:1075–1086.
  14. Kikugawa K, Kojima T, Yamaki S, Kosugi H: Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylediaminotetraacetic acid. Anal Biochem 1992;202:249–255.
  15. Adler M, Schaffner F: Fatty liver, hepatitis and cirrosis in obese patients. Am J Med 1979;67:811–816.
  16. Abrams GA, Kunde SS, Lazenby AJ, Clements RH: Portal fibrosis and hepatic steatosis in morbity obese subjects: a spectrum of non-alcoholic fatty liver disease. Hepatology 2004;40:475–483.
  17. Ludwig J, Viggiano TR, McGill DB, Oh BJ: Non alcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434–438.
  18. Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Malé PJ, Mentha G, Spahr L, Zarski JP, Borisch B, Hadengue A, Negro F: Hepatocyte steatosis is a cytopathic effect of hepatitis C genotype 3. J Hepatol 2000;33:106–115.
  19. Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L: Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005;54:1003–1008.
  20. Gutiérrez-Reyes G, Gutiérrez-Ruiz MC, Khersenobich D: Liver fibrosis and chronic viral hepatitis. Arch Med Res 2007;38:644–651.
  21. Ko WS, Guo CH, Yeh MS, Lin LY, Hsu GS, Chen PC, Luo MC, Lin CY: Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World J Gastroenterol 2005;11:4697–4702
  22. Wajchenberg BL, Gianella-Neto D, da Silva MER, Santos RF: Depot-specific hormonal characteristics of subcutaneous fat and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002;34:616–621.
  23. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM: Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2007;293:E656–E665.
  24. González-Reimers E, García-Valdecasas E, Santolaria-Fernández F, de la Vega-Prieto MJ, Ros-Vilamajó R, Martínez-Riera A, Rodríguez-Gaspar M: Proinflammatory cytokines in stable chronic alcoholics: relationships with lean and fat mass. Food Chem Toxicol 2007;45:904–909.
  25. Sánchez-Pérez MJ, González-Reimers E, Santolaria-Fernández F, de La Vega-Prieto MJ, Martínez-Riera A, González-Abreu P, Rodríguez-Rodríguez E, Durán-Castellón MC: Lipid peroxidation and serum cytokines in acute alcoholic hepatitis. Alcohol Alcohol 2006;41:593–597.

    External Resources

  26. Nelson DR, González-Peralta RP, Qian K, Xu Y, Marousis CG, Davis GL, Lau JY: Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepatitis 1997;4:29–35.
  27. Neuman MG, Benhamou JP, Malkiewicz IM, Ibrahim A, Valla DC, Martinot-Peignoux M, Asselah T, Bourliere M, Katz GG, Shear NH, Marcellin P: Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis. J Viral Hepatitis 2002;9:134–140.
  28. Spanakis NE, Garinis GA, Alexopoulos EC, Patrinos GP, Menounos PG, Sklavounou A, Manolis EN, Gorgoulis VG, Valis D: Cytokine serum levels in patients with chronic HCV infection. J Clin Lab Anal 2002;16:40–46.
  29. Roulot D, Durand H, Coste T, Rautureau J, Strosberg AD, Benarous R, Marullo S: Quantitative analysis of transforming growth factor beta 1 messenger RNA in the liver of patients with chronic hepatitis C: absence of correlation between high levels and severity of disease. Hepatology 1995;21:298–304.
  30. Benyon RC, Arthur MJ: Extracellular matrix degradation and the role of hepatic stellate cells. Sem Liver Dis 2001;21:373–384.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50